Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Evotec
(NASDAQ:EVO)
Intraday
$5.062
-2.588
[-33.83%]
After-Hours
$5.062
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$5.062
-2.588
[-33.83%]
At close: Apr 24
$5.062
0
[0.00%]
After Hours: 4:58PM EDT
Why is it moving?
Evotec shares are trading lower. The company reported FY23 financial results.
Get Report
Watch
Q4 2023 earnings announcement before the market open today
Today's conference call ended over 12 hours ago
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Evotec Stock (NASDAQ:EVO)
Evotec Stock (NASDAQ: EVO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
Crude Oil Moves Lower; B. Riley Financial Shares Jump
Avi Kapoor
-
2 hours ago
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
3 hours ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
4 hours ago
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
Avi Kapoor
-
5 hours ago
Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
Avi Kapoor
-
6 hours ago
Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast
Vandana Singh
-
7 hours ago
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
9 hours ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
9 hours ago
Evotec shares are trading lower. The company reported FY23 financial results.
Benzinga Newsdesk
-
9 hours ago
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
-
11 hours ago
Evotec Fiscal 2023 Revenue $848.644M Up From $816.11M YoY, Adjusted EBITDA $$.06M
Benzinga Newsdesk
-
14 hours ago
Tuesday, April 23, 2024
Evotec SE Appoints Dr Christian Wojczewski As CEO Effective July 1, 2024
Benzinga Newsdesk
-
1 day ago
Thursday, April 18, 2024
Evotec, Variant Bio Announce Collaboration Agreement To Identify Treatment For Diseases Caused By Fibrosis.
Benzinga Newsdesk
-
6 days ago
Wednesday, March 06, 2024
Evotec And Claris Ventures Streamline Access To Accelerate Programmes From Claris's Portfolio Companies Into The Clinic
Benzinga Newsdesk
-
Mar 6, 2024, 3:12AM
Tuesday, February 20, 2024
New Jersey Division Of Gaming Enforcement Has Closed Its Investigation Of Evolution AB With No Further Action
Benzinga Newsdesk
-
Feb 20, 2024, 2:57AM
Wednesday, February 07, 2024
Evotec Subsidiary Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV, Financial Terms Undisclosed
Benzinga Newsdesk
-
Feb 7, 2024, 2:03AM
Wednesday, January 10, 2024
What's Going On With Life Science Company Evotec Stock Today?
Nabaparna Bhattacharya
-
Jan 10, 2024, 1:21PM
'Evotec And Crohn's & Colitis Foundation Enter Agreement To Advance Drug Discovery For Novel IBD Therapies' - EQS News
Benzinga Newsdesk
-
Jan 10, 2024, 9:33AM
Monday, January 08, 2024
Evotec Advances Neuroscience Collaboration With Bristol Myers Squibb, Secures $25M Research Funding
Benzinga Newsdesk
-
Jan 8, 2024, 2:08AM
Thursday, January 04, 2024
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Jan 4, 2024, 1:37PM
Evotec shares are trading lower after the company announced a CEO transition.
Benzinga Newsdesk
-
Jan 4, 2024, 1:16PM
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 4, 2024, 7:59AM
Why Germany-Based Life Science Company Evotec Shares Are Falling Today
Nabaparna Bhattacharya
-
Jan 4, 2024, 7:11AM
Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
-
Jan 4, 2024, 5:46AM
Wednesday, January 03, 2024
Evotec Announces CEO Transition; Confirms Guidance 2023; CEO Dr Werner Lanthaler Steps Dowjn As CEO, Dr Mario Polywka, Former COO And Currently Member Of The Supervisory Board Has Agreed To Step In As Interim CEO
Benzinga Newsdesk
-
Jan 3, 2024, 12:32PM
Tuesday, December 19, 2023
Evotec Receives $2.5M Grant To Leverage Human Ipsc-Derived Teratogenicity Platform For Global Health Programmes
Benzinga Newsdesk
-
Dec 19, 2023, 2:12AM
Thursday, December 14, 2023
Evotec shares are trading higher after the company announced it entered a partnership with Charité to expand a molecular patient database for autoimmune diseases.
Benzinga Newsdesk
-
Dec 14, 2023, 11:47AM
Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases
Benzinga Newsdesk
-
Dec 14, 2023, 2:23AM
Monday, December 11, 2023
Glycotope and Evotec Enter Licensing Agreement to Combine Glycotope Antibodies and Evotec's Immune Cell Engager Platform
Benzinga Newsdesk
-
Dec 11, 2023, 2:23AM
Wednesday, December 06, 2023
Evotec's Partner Zhejiang Jingxin Pharmaceutical Secures Approval From Chinese Medical Authority For Evotec's Insomnia Drug, EVT201
Benzinga Newsdesk
-
Dec 6, 2023, 2:04AM
Wednesday, November 08, 2023
Earnings Scheduled For November 8, 2023
Benzinga Insights
-
Nov 8, 2023, 4:21AM
Evotec SE Reiterated FY23 Revenue €750M-€790M Bs $817.64M Est, Adj Group EBITDA of €60M-€80M
Benzinga Newsdesk
-
Nov 8, 2023, 2:37AM
Evotec SE Reports Revenue Growth of 14% YoY in 9M FY22 to € 580.1M, Adj Group EBITDA Increased by 13% YoY to € 50.2M
Benzinga Newsdesk
-
Nov 8, 2023, 2:33AM
Tuesday, November 07, 2023
A Preview Of Evotec's Earnings
Benzinga Insights
-
Nov 7, 2023, 9:01AM
Evotec And Dewpoint Therapeutics Enter A Strategic R&D Collaboration To Advance Dewpoint's Oncology Pipeline Programs
Benzinga Newsdesk
-
Nov 7, 2023, 2:59AM
Thursday, October 05, 2023
Evotec Enters BRIDGE Partnership With Lightstone, ClavystBio, Leaps By Bayer, And Polaris For '65LAB', Aims To Boost Drug Discovery In Asia
Benzinga Newsdesk
-
Oct 5, 2023, 3:11AM
Monday, October 02, 2023
Iama Therapeutics Announced To Sign A Multi-phase Agreement With Evotec
Benzinga Newsdesk
-
Oct 2, 2023, 7:46AM
Tuesday, September 26, 2023
Novo Nordisk And Evotec Announced LAB eN², A Translational Drug Discovery Accelerator To Accelerate The Translation Of Academic Ideas To Therapeutic Product Candidates In The Cardiometabolic Space
Benzinga Newsdesk
-
Sep 26, 2023, 7:50AM
Thursday, September 21, 2023
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Sep 21, 2023, 1:16PM
Thursday, August 31, 2023
What 4 Analyst Ratings Have To Say About Evotec
Benzinga Insights
-
Aug 31, 2023, 8:00AM
Salesforce To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Thursday
Lisa Levin
-
Aug 31, 2023, 7:37AM
HC Wainwright & Co. Maintains Buy on Evotec, Raises Price Target to $14
Benzinga Newsdesk
-
Aug 31, 2023, 6:17AM
Tuesday, August 29, 2023
Earnings Scheduled For August 29, 2023
Benzinga Insights
-
Aug 29, 2023, 4:36AM
Evotec Q2 EPS $(0.04) Misses $(0.04) Estimate, Sales $185.59M Miss $194.36M Estimate
Benzinga Newsdesk
-
Aug 29, 2023, 2:41AM
Monday, August 28, 2023
Evotec's Earnings Outlook
Benzinga Insights
-
Aug 28, 2023, 11:01AM
Thursday, July 27, 2023
Evotec Sees H1 Revenue €370M; Sees FY23 Revenue €750M-$790M
Benzinga Newsdesk
-
Jul 27, 2023, 2:19PM
Wednesday, July 12, 2023
Top Investment Bank Unveils 3 ETFs, 10 Stocks To Buy In The AI Boom
Piero Cingari
-
Jul 12, 2023, 4:18PM
HC Wainwright & Co. Reiterates Buy on Evotec, Maintains $12 Price Target
Benzinga Newsdesk
-
Jul 12, 2023, 6:10AM
Tuesday, July 11, 2023
Evotec And Bristol Myers Squibb Enter Exclusive Global Licence Agreement For Selected Programmes Developed And Progressed In The Collaboration
Benzinga Newsdesk
-
Jul 11, 2023, 2:03AM
Wednesday, July 05, 2023
Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories
Vandana Singh
-
Jul 5, 2023, 9:23AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch